Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Jan 2011 - Blood; 117(2):1528-0020 [PMID:21030562]
[Rosenblatt J] [Vasir B] [Uhl L] [Blotta S] [Macnamara C] [Somaiya P] [Wu Z] [Joyce R] [Levine JD] [Dombagoda D] [Yuan YE] [Francoeur K] [Fitzgerald D] [Richardson P] [Weller E] [Anderson K] [Kufe D] [Munshi N] [Avigan D]

Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
Dec 2010 - J. Immunother.; 34(1):1537-4513 [PMID:21150718]
[Röllig C] [Schmidt C] [Bornhäuser M] [Ehninger G] [Schmitz M] [Auffermann-Gretzinger S]

Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.
Aug 2010 - Br. J. Haematol.; 150(5):1365-2141 [PMID:20618329]
[Yi Q] [Szmania S] [Freeman J] [Qian J] [Rosen NA] [Viswamitra S] [Cottler-Fox M] [Barlogie B] [Tricot G] [van Rhee F]

Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
Feb 2010 - Biol. Blood Marrow Transplant.; 16(3):1523-6536 [PMID:19835972]
[Levenga H] [Schaap N] [Maas F] [Esendam B] [Fredrix H] [Greupink-Draaisma A] [de Witte T] [Dolstra H] [Raymakers R]

[Dendritic cell-based immunotherapy for multiple myeloma -- review]
Jun 2009 - Zhongguo Shi Yan Xue Ye Xue Za Zhi; 17(3):1009-2137 [PMID:19549416]
[Zhu XJ] [He L] [Sun XM]

[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]
Jun 2009 - Klin Onkol; 22(2):0862-495X [PMID:19522376]
[Ocadlíková D] [Zahradová L] [Kovárová L] [Smejkalová J] [Pour L] [Vidláková P] [Kyjovská D] [Moravcová J] [Rycová M] [Novotná H] [Jelínková I] [Penka M] [Michálek J] [Hájek R]

Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma.
Jan 2009 - J. Immunol.; 182(3):1550-6606 [PMID:19155516]
[Cohen S] [Haimovich J] [Hollander N]

Immunotherapy of hematological malignancies using dendritic cells.
Apr 2008 - Bull Cancer; 95(3):1769-6917 [PMID:18390412]
[Van de Velde AL] [Berneman ZN] [Van Tendeloo VF]

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
Oct 2007 - Br. J. Haematol.; 139(3):0007-1048 [PMID:17910631]
[Curti A] [Tosi P] [Comoli P] [Terragna C] [Ferri E] [Cellini C] [Massaia M] [D'Addio A] [Giudice V] [Di Bello C] [Cavo M] [Conte R] [Gugliotta G] [Baccarani M] [Lemoli RM]

Current status of immunotherapy in B cell malignancies.
Nov 2006 - Curr Drug Targets; 7(10):1873-5592 [PMID:17073599]
[Kofler DM] [Mayr C] [Wendtner CM]

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma.
Jun 2006 - Cytotherapy; 8(3):1465-3249 [PMID:16793736]
[Guardino AE] [Rajapaksa R] [Ong KH] [Sheehan K] [Levy R]

[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
Mar 2006 - Zhonghua Xue Ye Xue Za Zhi; 26(10):0253-2727 [PMID:16532967]
[Zhang M] [Yin XR] [Luo YY] [Lin X] [Wang MC] [He PC] [Li J] [Guo GL] [Cai RH] [Liu YL]

Vaccine strategies to treat lymphoproliferative disorders.
Jan 2006 - Pathology; 37(6):0031-3025 [PMID:16373232]
[Radford KJ] [Vari F] [Hart DN]

Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.
Dec 2005 - Leuk. Lymphoma; 47(1):1042-8194 [PMID:16321824]
[Bendandi M] [Rodríguez-Calvillo M] [Inogés S] [López-Díaz de Cerio A] [Pérez-Simón JA] [Rodríguez-Caballero A] [García-Montero A] [Almeida J] [Zabalegui N] [Giraldo P] [San Miguel J] [Orfao A]

Dendritic cells in clinical trials for multiple myeloma.
Dec 2004 - Methods Mol. Med.; 109:1543-1894 [PMID:15585918]
[Reichardt VL] [Brossart P]